Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 02, 2007 07:00 ET | Source: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Reports Third Quarter 2007 Financial Results

HOUSTON, Nov. 2, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced financial results for the third quarter ended September 30, 2007. "We made excellent progress in...
October 30, 2007 08:00 ET | Source: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals to Present At the Acumen BioFin Rodman and Renshaw Healthcare Conference

HOUSTON, Oct. 30, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) announced today that George Cole, Encysive's President and Chief Executive Officer, will present at the 9th Annual...
October 24, 2007 16:01 ET | Source: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Announces Long-Term Study of Sitaxsentan Presented At Chest Meeting

CHICAGO, Oct. 24, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced that data from a long-term study with sitaxsentan sodium 100 mg tablets (THELIN(tm)) in patients...
October 16, 2007 13:00 ET | Source: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Announces Conference Call to Discuss Third Quarter 2007 Results

HOUSTON, Oct. 16, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) will hold an investor conference call on Friday, November 2, 2007 at 8:00 a.m. ET to discuss its third quarter...
October 11, 2007 02:00 ET | Source: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Launches THELIN (Sitaxentan Sodium) in France

HOUSTON, Oct. 11, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced the commercial availability of THELIN(r)(1) (sitaxentan sodium(2)) 100 mg tablets in France for the...
September 24, 2007 07:00 ET | Source: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals to Conduct Phase III Study With Thelin (Sitaxsentan Sodium) in Pulmonary Arterial Hypertension

HOUSTON, Sept. 24, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced that the Company will move forward with plans to conduct an additional Phase III study...
September 21, 2007 16:01 ET | Source: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Refinances Argatroban Royalty Notes

HOUSTON, Sept. 21, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced that its special purpose subsidiary, Argatroban Royalty Sub LLC ("Royalty Sub"), has refinanced...
September 19, 2007 07:00 ET | Source: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Announces Dismissal of Class Action Lawsuit

HOUSTON, Sept. 19, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced that the United States District Court for the Southern District of Texas has dismissed, with...
September 13, 2007 02:00 ET | Source: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Announces Launch of THELIN (sitaxentan sodium) in Spain

HOUSTON, Sept. 13, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced the commercial availability of THELIN(r)(1) (Sitaxentan sodium(2)) 100 mg tablets in Spain for the...
September 06, 2007 16:05 ET | Source: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Announces Presentation/Webcast At UBS Global Life Sciences Conference

HOUSTON, Sept. 6, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) announced today that it will participate in the 2007 UBS Global Life Sciences Conference, being held at the Grand...